Target intelligence / Profile preview

High mobility group AT-hook 2 mRNA 3'-untranslated region (HMGA2 mRNA 3'-UTR)

Target
HMGA2 mRNA 3'-UTR
Molecular classification
Messenger RNA (mRNA), Regulatory RNA element
01

Overview

The HMGA2 mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the High Mobility Group AT-Hook 2 transcript, spanning approximately 3 kilobases and containing multiple evolutionary conserved binding sites for the let-7 microRNA family. Under normal physiological conditions, let-7 binds to this region to suppress HMGA2 expression, thereby regulating cell proliferation and differentiation. In many cancers, chromosomal translocations or deletions lead to the loss of the 3'-UTR, resulting in 'let-7-mediated escape' and subsequent overexpression of the HMGA2 protein, which drives oncogenic processes such as the epithelial-mesenchymal transition (EMT) and metastasis. As a therapeutic target, the HMGA2 mRNA 3'-UTR is being explored for the development of RNA-targeted therapies, including antisense oligonucleotides and small molecules designed to either mimic microRNA suppression or prevent the oncogenic stabilization of the transcript. Targeting this region offers a strategy to downregulate a potent driver of tumor progression that is otherwise difficult to inhibit at the protein level.

Other names
HMGA2 3'-UTRHMGA2 3-prime untranslated regionHigh-mobility group protein HMGI-C mRNA 3'-UTR
02

Mechanism of action

Modulation of mRNA stability and translation efficiency through the competitive inhibition or enhancement of microRNA binding (specifically the let-7 family) or through antisense-mediated degradation of the transcript.

03

Biological functions

Regulation of gene expressionmRNA stability regulationTranslation regulationEpithelial-mesenchymal transition (EMT)Stem cell self-renewal
04

Disease associations

CancerObesityUterine leiomyomaLipoma
05

Safety considerations

Off-target effects on other mRNAs containing let-7 binding sitesPotential for systemic toxicity from RNA-delivery vehiclesDisruption of normal stem cell niches where HMGA2 is physiologically active
06

Interacting drugs

Let-7 microRNA (endogenous)

2 more in the full profile.

07

Biomarkers

HMGA2 protein expression levelsLet-7 microRNA expression levelsHMGA2 mRNA truncation status

Beyond the preview

Go deeper on High mobility group AT-hook 2 mRNA 3'-untranslated region (HMGA2 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group AT-hook 2 mRNA 3'-untranslated region (HMGA2 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call